ESR2 and colorectal carcinoma: Furthermore, studies conducted by Hases et al. on a mouse model established that the protective mechanism of ERβ in CRC consists in its direct binding to NF-κB activators, thereby inhibiting their activity while stimulating the expression of the NF-κB inhibitor [142].